Sterling Capital Management »

Xeris Pharmaceuticals shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $404 142 2.85

More positions owned by Sterling Capital Management

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Vanguard S&p 500 Etf Etf (VOO)
Hershey Company (HSY)
Automatic Data Processing (ADP)
Home Depot (HD)
Anthem (ELV)
Ameriprise Financial (AMP)
Analog Devices (ADI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Nasdaq Omx (NDAQ)
Abbvie (ABBV)
Pepsi (PEP)

View all positions for Sterling Capital Management

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals